Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Monday, January 4, 2021

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Cancer shared this article with you from Inoreader

1.cover-source.jpg

View on the web

No comments:

Post a Comment